Association between age at first sexual intercourse and subsequent human papillomavirus infection: Results of a Brazilian screening program;Associação entre idade ao início da atividade sexual e subsequente infecção por papilomavírus humano: Resultados de um programa de rastreamento brasileiro

Revista Brasileira de Ginecologia e Obstetricia

Volumn 29, Issue 11, 2007, Pages 580-587

  Roteli Martins, Cecília Maria ^a,b,c,d   Filho, Adhemar Longatto ^b,e,f   Hammes, Luciano Serpa ^b,g,h   Derchain, Sophie Françoise Mauricette ^b,c   Naud, Paulo ^b,i   De Matos, Jean Carlos ^b,g   Etlinger, Daniela ^b,e   Sarian, Luis ^b,c   Gontijo, Renata Clemntino ^b,c   Maeda, Marina Yoshiê Sakamoto ^b,e   Syrjänen, Kari Juhani ^b,j  

^a Programa INCO DEV ^*  (Brazil)

^b Programa INCO DEV (International Cooperation Development)   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS   (Brazil)

^e INSTITUTO ADOLFO LUTZ   (Brazil)

^f UNIVERSITY OF MINHO   (Portugal)

^g FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^h HOSPITAL MOINHOS DE VENTO   (Brazil)

ⁱ HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^j UNIVERSITY OF TURKU   (Finland)

more..

Author keywords

Papillomavirus infections diagnosis; Risk factors; Sexual behavior; Uterine cervical neoplasms prevention control; Vaccine therapeutic use; Vaginal smears

Indexed keywords

EID: 41149120644     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Castle PE, Schiffmann M, Herrero R, Hildesheim A, Rodríguez AC, Bratti MC, el al. A prospective study of age trends in cervical humman papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis. 2005;191(11):1808-16.
2. Giuliana AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis. 2002;186(4):462-9.
3. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA. 2001;286(24):3106-14.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1): 12-9.
5. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses. Lyon: IARC; 1995. v. 64.
6. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses. Lyon: IARC; 2005. v. 90.
7. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338(7):423-8.
8. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):24445.
9. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000;151(12):1158-71.
10. Bekkers RL, Meijer CJ, Massuger LF, Snijders PJ, Melchers WJ. Effects of HPV detection in population-based screening programmes for cervical cancer: a Dutch moment. Gynecol Oncol. 2006;100(3):451-4
11. Bory JP, Cucherousset J, Lorenzato M, Gabriel R, Quereux C, Birembaut P, et al. Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. Int J Cancer. 2002;102(5):519-25.
12. Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD. The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women. J Pediatr. 2002;141(5):718-23.
13. Baseman JG, Koulsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32 Suppl 1:S16-24.
14. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102(5A):3-8.
15. Moscicki AB. HPV infections in adolescents. Dis Markers. 2007;23(4):229-34.
16. Kahn JA, Rosenthal SL, Succop PA Ho GY, Burk RD. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics. 2002;109(1):E5.
17. Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine. 2006;24(27-28):5571-83.
18. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent LI virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367(9518):124755.
19. Bosch X, Harper D. Prevention strategies of cervical cancer in the HPV vaccine era. Gynecol Oncol. 2006;103(1):21-4.
20. Syrjänen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, et al. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res. 2005;25(5):3469-80.
21. Signorelli C, Colzani E. Age at first intercourse and HPV immunization. J Prev Med Hyg. 2007;48(2):37-8.
22. International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 2007;120(4):885-91.
23. Collins SI, Mazloomzadeh S, Winter H, Rollason TP, Blomfield P, Young LS, et al. Proximity of first intercourse to menarche and the risk of human papillomavirus infection: a longitudinal study. Int J Cancer. 2005;114(3):498-500.
24. Moscicki AB. Cervical cytology screening in teens. Curr Womens Health Rep. 2003;3(6):433-7.
25. Trottier H, Franco EL. Human papillomavirus and cervical cancer: burden of illness and basis for prevention. Am J Manag Care. 2006;12(17 Suppl):S462-72.
26. Kjaer S, Hogdall E, Frederiksen K, Munk C, van den Brule A, Svare E, et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res. 2006;66(21):10630-6
27. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327(18):1272-8.
28. Pereira CR, Rosa ML, Vasconcelos GA, Faria PC, Cavalcanti SM, Oliveira LH. Human papillomavirus prevalence and predictors for cervical cancer among high-risk women from Rio de Janeiro, Brazil. Int J Gynecol Cancer. 2007;17(3):651-60.
29. Bosch FX, Munoz N, De Sanjose S, Izarzugaza I, Gili M, Viladiu P, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer. 1992;52(5):750-8.
30. Moscicki AB, Schiffman M, Kjaer S, Villa LL Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006;24 Suppl 3:S42-51.
31. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157(3):218-26.
32. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006;208(2):152-64.
33. Moscicki AB, Hills N, Shiboski S, Powel K, Jay N, Hanson E, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 2001;285(23):2995- 3002.
34. Naud P, Matos J, Hammes L, Stuckzynski J, Brouwers K, Magno V, et al. Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil. Eur J Obstet Gynecol Reprod Biol. 2006;124(1):110-8.
35. Leite APL. Sexualidade na adolescência: conhecimentos, atitudes e práticas dos adolescentes estudantes do município de Maceió. Rev Bras Ginecol Obstet. 2001;23(2):124. Crosbie EJ, Kitchener HC. Human papillomavirus in cervical screening and vaccination. Clin Sei (Lond). 2006;110(5):543-52.
36. Arbyn M, DillnerJ. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. J Clin Virol. 2007,-38(3):189-97.
37. Manhart LE, Holmes KK, Koutsky LA, Wood TR, Kenney DL, Feng Q, et al. Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy. Sex Transm Dis. 2006;33(8):502-8.
38. Kahn JA. Vaccination as a prevention strategy for human papillomavirus-relaled diseases. J Adolesc Health. 2005;37(6 Suppl):S10-6.